Bromide

Bromide

SCHEMBL7519081

Clc1ccc([P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1.[Br-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
CYP1A2 P05177 1/20 0.48
LMNA P02545 2/20 0.42
CYP2A6 P11509 1/20 0.42
IDO1 P14902 2/20 0.40
TDO2 P48775 2/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
ORAI1 Q96D31 1/20 0.39
ORAI2 Q96SN7 1/20 0.39
ORAI3 Q9BRQ5 1/20 0.39
TRPV6 Q9H1D0 1/20 0.39
CHRNA7 P36544 1/20 0.38
NOX1 Q9Y5S8 1/20 0.38
CNR1 P21554 1/20 0.36
HIF1A Q16665 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7064404 0.97 TSHR (0.48) TSHRCYP1A2LMNACYP2A6IDO1
Iodide SCHEMBL7517751 0.95 TSHR (0.50) TSHRCYP1A2LMNACYP2A6IDO1
Hydrochloric Acid SCHEMBL7063181 0.95 TSHR (0.50) TSHRCYP1A2LMNACYP2A6IDO1
Bromide SCHEMBL7874765 0.89 LMNA (0.53) TSHRCYP1A2LMNACYP2A6IDO1
SCHEMBL11324654 0.88 TSHR (0.43) TSHRCYP1A2LMNACYP2A6IDO1
SCHEMBL10884086 0.88 TSHR (0.43) TSHRCYP1A2LMNACYP2A6IDO1
SCHEMBL7060292 0.88 CYP1A2 (0.48) TSHRCYP1A2LMNACYP2A6IDO1
SCHEMBL10884076 0.84 TSHR (0.40) TSHRCYP1A2LMNACYP2A6IDO1
SCHEMBL7060290 0.84 TSHR (0.40) TSHRCYP1A2LMNACYP2A6IDO1
Iodide SCHEMBL7901726 0.83 LMNA (0.53) TSHRCYP1A2LMNACYP2A6IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9174918-B2 Process for preparing diaryl oxalate UBE INDUSTRIES, LTD. (JP) 2015-11-03 US disclosed
US-20120296063-A1 PROCESS FOR PREPARING DIARYL OXALATE UBE CORPORATION (JP) 2012-11-22 US disclosed
EP-0832910-B1 Process for producing a polycarbonate UBE INDUSTRIES (JP) 2002-06-26 EP disclosed
EP-0832872-B1 Process for producing diaryl carbonate UBE INDUSTRIES (JP) 2002-01-30 EP disclosed
EP-0834496-B1 Preparation of diaryl carbonate UBE INDUSTRIES (JP) 2001-08-16 EP disclosed
US-6169209-B1 BRINGING AN ORGANIC PHOSPHONIUM BROMIDE INTO CONTACT WITH A CHLORIDE ION IN A HETEROGENEOUS MIXTURE SOLUTION COMPRISING WATER AND AN ORGANIC SOLVENT TO FORM ORGANIC PHOSPHONIUM CHLORIDE UBE INDUSTRIES, LTD. (JP) 2001-01-02 US disclosed
EP-0834495-B1 Process for preparing diaryl carbonate UBE INDUSTRIES (JP) 2000-12-27 EP disclosed
US-5922827-A Process for producing a polycarbonate UBE INDUSTRIES, LTD. (JP) 1999-07-13 US disclosed
US-5892089-A FROM DIARYL OXALATE IN LIQUID PHASE BY DECARBONYLATION USING ORGANIC PHOSHORUS COMPOUND CATALYST UBE INDUSTRIES, LTD. (JP) 1999-04-06 US disclosed
US-5892091-A PHOSPHOROUS CATALYSTS AND HALOGEN ATOMS UBE INDUSTRIES, LTD. (JP) 1999-04-06 US disclosed
EP-0834496-A1 Preparation of diaryl carbonate UBE INDUSTRIES, LTD. (JP) 1998-04-08 EP disclosed
EP-0832910-A2 Process for producing a polycarbonate UBE INDUSTRIES, LTD. (JP) 1998-04-01 EP disclosed
EP-0832872-A1 Process for producing diaryl carbonate UBE INDUSTRIES, LTD. (JP) 1998-04-01 EP disclosed
EP-0826658-A1 Catalyst for decarbonylation reaction UBE INDUSTRIES, LTD. (JP) 1998-03-04 EP disclosed
US-5648510-A DECARBONYLATION OF OXALATE UBE INDUSTRIES, LTD. (JP) 1997-07-15 US disclosed
EP-0737665-A1 Process for preparation of diaryl carbonate UBE INDUSTRIES, LTD. (JP) 1996-10-16 EP disclosed
EP-0220810-B1 INSECTICIDAL ETHERS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-05-02 EP disclosed
US-4788348-A HYDROXY AROMATIC ETHERS AS CHEMICAL INTERMEDIATES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-11-29 US disclosed
US-4705900-A Insecticidal alkenes IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-11-10 US disclosed
EP-0220810-A1 Insecticidal ethers IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120296063-A1 PROCESS FOR PREPARING DIARYL OXALATE TH, CYP2E1, ADH1A TSHR 1038/4885CYP1A2 13/4885LMNA 3146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.